Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.

Breast cancer research and treatment - 1 Jul 2014

Tung Nadine, Gaughan Elizabeth, Hacker Michele R, Lee Larissa J, Alexander Brian, Poles Emily, Schnitt Stuart J, Garber Judy E

Abstract excerpt

The majority of breast cancers developing in BRCA1 mutation carriers are triple negative breast cancers (TNBC), an aggressive subtype that accounts for 15-20 % of sporadic breast cancer. We compare the clinical outcome and sites of relapse of TNBC in BRCA1 mutation carriers and non-carriers who received adjuvant chemotherapy. Women with stage I-III TNBC who had BRCA1 testing within 36 months of diagnosis and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, BRCA1
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Patient Outcome Assessment

Share to Population Surveillance

Share to Survival Analysis

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 24839033
DOI: 10.1007/s10549-014-2995-6

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.PMID 24839033Read ↗

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.Semantic proximity Read ↗

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.Semantic proximity Read ↗

Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.Semantic proximity Read ↗

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.Semantic proximity Read ↗

BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survivalSemantic proximity Read ↗

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.Semantic proximity Read ↗

Tumor characteristics and prognosis in familial breast cancer.Semantic proximity Read ↗

Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis.Semantic proximity Read ↗

Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.Semantic proximity Read ↗

BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.Semantic proximity Read ↗

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.Semantic proximity Read ↗

Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical PrognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.